Piper Sandler & Co’s Oxford Immunotec Global OXFD Stock Holding History
Bought
Maintained
Sold
Other funds holding OXFD
Piper Sandler & Co's OXFD Position: Q2 2016 in Review
Piper Sandler & Co sold out of Oxford Immunotec Global (OXFD) in Q2 2016, closing a stake of 65 shares — an estimated $1K sold.
Piper Sandler & Co first reported a position in OXFD in Q4 2014 and held it in 6 quarters. The position peaked at $419K in Q1 2015. 56 funds tracked by Wall St. Rank hold OXFD as of Q2 2016.
- Piper Sandler & Co reported no remaining Oxford Immunotec Global position as of Q2 2016 after selling out during the quarter.
- Piper Sandler & Co sold 65 Oxford Immunotec Global shares in Q2 2016, an estimated $1K.
- Piper Sandler & Co first reported a position in Oxford Immunotec Global in Q4 2014 and held it in 6 quarters.
- Piper Sandler & Co's Oxford Immunotec Global position peaked at $419K in Q1 2015.
- 56 funds tracked by Wall St. Rank held Oxford Immunotec Global as of Q2 2016.
Based on Piper Sandler & Co's 13F filing for Q2 2016, filed 15 Aug 2016.